Merck&Co Earnings, Revenue Beat in Q1
2022.04.28 14:14
Merck&Co Earnings, Revenue Beat in Q1
Investing.com – Merck&Co reported on Thursday first quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Merck&Co announced earnings per share of $2.14 on revenue of $15.9B. Analysts polled by Investing.com anticipated EPS of $1.83 on revenue of $14.56B.
Merck&Co shares are up 3% from the beginning of the year, still down 7.65% from its 52 week high of $91.40 set on November 4, 2021. They are outperforming the S&P 500 which is down 12.22% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
